0001567619-22-005791.txt : 20220228 0001567619-22-005791.hdr.sgml : 20220228 20220228165045 ACCESSION NUMBER: 0001567619-22-005791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220225 FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cambrian BioPharma Inc CENTRAL INDEX KEY: 0001797409 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39980 FILM NUMBER: 22690742 BUSINESS ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: #66643 CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: (516) 962-3186 MAIL ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: #66643 CITY: NEW YORK STATE: NY ZIP: 10003 FORMER NAME: FORMER CONFORMED NAME: Cambrian BioPharma Inc. DATE OF NAME CHANGE: 20191219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sensei Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001829802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 PROFESSIONAL DRIVE CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: (240) 243-8000 MAIL ADDRESS: STREET 1: 620 PROFESSIONAL DRIVE CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2022-02-25 0 0001829802 Sensei Biotherapeutics, Inc. SNSE 0001797409 Cambrian BioPharma Inc 19 MORRIS AVENUE BROOKLYN NAVY YARD, BUILDING 128 BROOKLYN NY 11205 0 0 1 0 Common Stock 2022-02-25 4 P 0 2500 3.65 A 5228286 D These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares. Cambrian BioPharma Inc, by: /s/ James Peyer 2022-02-28